Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Peter W, Hellings"'
Autor:
Amber U. Luong, MD, PhD, Joshua M. Levy, MD, MPH, MSc, Ludger Klimek, MD, PhD, Richard J. Harvey, MD, Jared Silver, MD, PhD, Steven G. Smith, PhD, Abby Fuller, MSc, Robert Chan, MD, Peter W. Hellings, MD, PhD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 4, Pp 100327- (2024)
Background: In the phase III SYNAPSE study, mepolizumab plus standard of care reduced total endoscopic nasal polyp score (NPS) versus that with placebo in patients with chronic rhinosinusitis with nasal polyps. Objective: Our aim was to investigate r
Externí odkaz:
https://doaj.org/article/fd28a8839e0744b1ad824720015c58c9
Autor:
Tine Wils, Wout Backaert, Inge Jacobs, Emma Ruysseveldt, Jonathan Cremer, Ellen Dilissen, Dominique M. Bullens, Karel Talavera, Brecht Steelant, Laura Van Gerven, Katleen Martens, Peter W. Hellings
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
There is growing evidence that neurogenic inflammation contributes to the pathophysiology of upper airway diseases, with nasal hyperreactivity (NHR) being a key symptom. The rare neuroendocrine cells (NECs) in the epithelium have been linked to the p
Externí odkaz:
https://doaj.org/article/ae59f63ec13145aa8efa1b98457e1787
Autor:
Diego M. Conti, Peter W. Hellings, Zuzana Diamant, Leif Bjermer, Milos Jesenak, Vibeke Backer, Wytske Fokkens, Susanne Lau, Elizabeth Van Staeyen, Glenis K. Scadding
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 19, Iss 1, Pp 1-4 (2023)
Abstract “Epidemiology of comorbidities and their association with asthma control” (Tomisa, G., Horváth, A., Sánta, B. et al. Epidemiology of comorbidities and their association with asthma control. Allergy Asthma Clin Immunol 17, 95 (2021). ht
Externí odkaz:
https://doaj.org/article/461669d6f6db48f899f001e66356d3dc
Autor:
Oliver Pfaar, MD, PhD, Frédéric De BLAY, MD, Giorgio Walter Canonica, MD, Thomas B. Casale, MD, PhD, Philippe Gevaert, MD, PhD, Peter W. Hellings, MD, PhD, Krzysztof Kowal, MD, PhD, Giovanni Passalacqua, MD, Miguel Tortajada-Girbés, MD, PhD, Carmen Vidal, MD, PhD, Margitta Worm, MD, PhD, Farah Bahbah, MD, Pascal Demoly, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 17, Iss 1, Pp 100849- (2024)
Background: House dust mite (HDM)-induced allergic rhinitis (AR) is a major cause of allergic respiratory disease. The efficacy and safety of the 300 IR HDM sublingual immunotherapy (SLIT) tablet in patients with moderate-to-severe HDM-AR was confirm
Externí odkaz:
https://doaj.org/article/43594bc3e5774527b1542f3db97a9f03
Autor:
Sven F. Seys, Senne Gorris, Saartje Uyttebroek, Wout Backaert, Mark Jorissen, Rik Schrijvers, Rembert Daems, Dirk Loeckx, Laura Van Gerven, Peter W. Hellings
Publikováno v:
Frontiers in Allergy, Vol 4 (2023)
BackgroundThe skin prick test (SPT) is the gold standard for identifying allergic sensitization in individuals suspected of having an inhalant allergy. Recently, it was demonstrated that SPT using a novel skin prick automated test (SPAT) device showe
Externí odkaz:
https://doaj.org/article/a7c4a81c05684d18b27596751396dc75
Publikováno v:
Frontiers in Allergy, Vol 4 (2023)
Nonsteroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease (N-ERD) is a clinical syndrome characterized by nasal polyposis, asthma, and intolerance to aspirin/NSAID. It affects approximately 15% cases of severe asthma, 10% of nasal p
Externí odkaz:
https://doaj.org/article/1a3336b6532543cc9eb6b6cdbf5aa477
Autor:
Patricia K. Kakobo, Hilaire K. Kalala, Joseph K. Kelekele, Paulin B. Mutombo, Dieudonné T. Nyembue, Peter W. Hellings, Jean-Marie N. Kayembe
Publikováno v:
Frontiers in Allergy, Vol 4 (2023)
ObjectiveTo identify the determinants of uncontrolled allergic rhinitis (UCAR) in a hospital setting in Kinshasa, Democratic Republic of Congo.MethodsHospital-based cross-sectional study of 153 patients with allergic rhinitis (AR). The diagnosis of A
Externí odkaz:
https://doaj.org/article/5118e93dd281489aba335df92baabb50
Autor:
Vibeke Backer, Lars Olaf Cardell, Lauri Lehtimäki, Sanna Toppila-Salmi, Leif Bjermer, Sietze Reitsma, Peter W. Hellings, Dan Weinfeld, Kasper Aanæs, Charlotte Suppli Ulrik, Gert-Jan Braunstahl, Bernt Bøgvald Aarli, Arild Danielsen, Hannu Kankaanranta, Sverre Steinsvåg, Claus Bachert
Publikováno v:
Frontiers in Allergy, Vol 4 (2023)
BackgroundChronic rhinosinusitis with nasal polyps (CRSwNP) and asthma frequently co-exist and share pathologic features. Taking a “global” treatment approach benefits diagnosis and treatment of both, but care is often siloed by specialty: joined
Externí odkaz:
https://doaj.org/article/969ba5836e5c4867b048d1fd9219ceee
Multiple reasons underlaying uncontrolled disease in the majority of chronic rhinosinusitis patients
Autor:
An-Sofie Viskens, Tine Wils, Pauline Van Bulck, Leen Cools, Olivier Vanderveken, Peter W. Hellings
Publikováno v:
Frontiers in Allergy, Vol 3 (2022)
BackgroundUp to 40% of patients with chronic rhinosinusitis (CRS) remain uncontrolled despite guidelines of care being available, with an enormous socio-economic impact. The reasons for uncontrolled disease can be arbitrarily divided into disease-rel
Externí odkaz:
https://doaj.org/article/088ea173493d46508762369aff3135df
Autor:
Shahid Siddiqui, Claus Bachert, Adam M. Chaker, Joseph K. Han, Peter W. Hellings, Anju T. Peters, Enrico Heffler, Siddhesh Kamat, Haixin Zhang, Scott Nash, Asif H. Khan, Lucia De Prado Gomez, Juby A. Jacob-Nara, Paul J. Rowe, Yamo Deniz
Publikováno v:
ERJ Open Research, Vol 8, Iss 4 (2022)
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a predominantly type 2 inflammatory disease of the nasal and paranasal sinuses. Dupilumab is a monoclonal antibody that blocks the shared receptor component for interleukin-4 and interleukin-13, wh
Externí odkaz:
https://doaj.org/article/bd6ab2fceb3e47b39463130f9fec492b